Log in
Enquire now
‌

US Patent 11046725 Galactoside inhibitor of galectins

Patent 11046725 was granted and assigned to Galecto Biotech on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Galecto Biotech
Galecto Biotech
Current Assignee
Galecto Biotech
Galecto Biotech
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11046725
Date of Patent
June 29, 2021
Patent Application Number
16960996
Date Filed
January 9, 2019
Patent Citations Received
‌
US Patent 11919921 Galactoside inhibitor of galectins
0
‌
US Patent 11377464 Galactoside inhibitor of galectins
Patent Primary Examiner
‌
Traviss C Mcintosh, III
Patent abstract

An α-D-galactopyranose compound of the general formula (1). The α-D-galactopyranose compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human. Furthermore, a method for treatment of a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11046725 Galactoside inhibitor of galectins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.